Table 1.
Researches showing anti-inflammatory properties of NSCs
Reference | Model | Cell type | Transplantation method | CNS homing | Systemic distribution | Anti-inflammation | Effects on inflammatory cells |
---|---|---|---|---|---|---|---|
Pluchino et al., 2003 | Mouse EAE | Murine neural progenitors | Intravenous, intracerebroventricular | Positive | Spleen, kidney, liver, lung, gut | Positive | Reduced inflammatory cytokines (MMP, TNF) |
Pluchino et al., 2005 | Mouse EAE | Murine neural progenitors | Intravenous | Positive | Liver, spleen, kidney | Positive | Apoptosis of Th1 cells |
Einstein et al., 2005 | Mouse EAE | Murine neural progenitors | Intracerebroventricular | Positive | Not tested | Positive | Decreasing Th1 cell and increasing Treg cells |
Einstein et al., 2007 | Mouse EAE | Murine neural progenitors | Intravenous | Negative | Spleen, lymph nodes | Positive | Inhibiting Th1 proliferation and activation |
Capone et al., 2007 | Mouse cerebral ischemia | Murine neural progenitors | Intracerebroventricular | Positive | Not tested | Positive | Reducing activated microglia |
Lee et al., 2008 | Rat intracerebral hemorrhage | Human fetal neural stem cells | Intravenous, at acute stage (2hr after ICH) | Rare | Spleen, lung, liver, brain | Positive | Inhibiting splenic macrophage activation |
Aharonowiz et al., 2008 | Mouse EAE | Human ESC-derived neural progenitors | Intracerebroventricular | Positive | Not tested | Positive | Inhibiting Th1 cell activation and reducing macrophage infitration |